XOMA Royalty to Present at Upcoming Investor Conferences in September

Core Insights - XOMA Royalty Corporation will participate in two upcoming investor conferences in September 2024, presenting corporate overviews at both events [1][2]. Group 1: Upcoming Conferences - XOMA will present at the H.C. Wainwright 26th Annual Global Investment Conference from September 9-11, 2024, in New York, with a presentation scheduled for September 9 at 9:00 AM ET [1]. - The company will also present at the 2024 Cantor Global Healthcare Conference from September 17-19, 2024, in New York, with a presentation on September 17 at 2:30 PM ET [1]. Group 2: Access to Presentations - Presentations can be accessed via the investor relations section of XOMA's website, and replays will be available for 90 days post-event [2]. Group 3: Company Overview - XOMA Royalty Corporation operates as a biotechnology royalty aggregator, acquiring future economic rights associated with therapeutic candidates licensed to pharmaceutical or biotech companies [3]. - The company provides non-dilutive, non-recourse funding to sellers, enabling them to advance their drug candidates or for general corporate purposes [3]. - XOMA has a growing portfolio of assets, defined as rights to receive potential future economics from therapeutic candidates [3].